Relationship Between Biological Marker Expression and Fluorine-18 Fluorodeoxyglucose Uptake in Incidentally Detected Thyroid Cancer
Authors:
- 1 June 2010
- journal article
- research article
- Published by SAGE Publications in Cancer Biotherapy and Radiopharmaceuticals
- Vol. 25 (3) , 309-315
Abstract
The aim of this study was to investigate the underlying mechanisms associated with fluorine-18 fluorodeoxyglucose (F-18 FDG) uptake in an incidentally detected thyroid cancer during nonthyroid cancer evaluation. Among 92 patients (10 men and 82 women; mean age, 56.2 ± 10.9 years; age range, 26–78 years) with focal thyroid FDG uptake during nonthyroid cancer evaluation, 14 patients with cytologically confirmed papillary thyroid cancer were included. For semiquantitative analysis, the maximal standardized uptake value was calculated. Immunohistochemical studies were performed for hypoxia inducible factor 1 alpha (HIF1α), HIF2α, glucose transporter 1 (GLUT1), GLUT3, carbonic anhydrase IX (CA-IX), hexokinase type II (HK II), and vascular endothelial growth factor (VEGF). The significant findings of this study were as follows: (1) a lack of HIF1α and HIF2α expression; (2) low-degree expression of GLUT1 (1 patient), GLUT3 (5 of 14 patients), HK II (3 of 14 patients), and CA-IX (1 patient); and (3) high degree expression of VEGF (all 14 patients). The data presented in this study indicate that F-18 FDG uptake in incidentally detected thyroid cancer was not related to hypoxia-induced upregulation of GLUT1, GLUT3, CA-IX, and HK II. Ki-67 expression was not associated with F-18 FDG uptake. However, all incidentally detected thyroid cancers showed a high degree of expression of VEGF.Keywords
This publication has 27 references indexed in Scilit:
- Clinical implication of F-18 FDG PET/CT for differentiated thyroid cancer in patients with negative diagnostic iodine-123 scan and elevated thyroglobulinEuropean Journal of Radiology, 2009
- Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancerBritish Journal of Cancer, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Role of 18F-fluorodeoxyglucose positron emission tomography imaging in surgery for pancreatic cancerWorld Journal of Gastroenterology, 2008
- Early Prediction of Therapy Outcome in Patients with High-Risk Soft Tissue Sarcoma Using Positron Emission TomographyOnkologie, 2008
- PET con 18FDG en pacientes con cáncer diferenciado de tiroides que presentan niveles elevados de tiroglobulina sérica y rastreos con 131I negativosRevista Española de Medicina Nuclear, 2005
- Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2000
- FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor modelsNuclear Medicine and Biology, 1994
- Transformation of Rat Fibroblasts by FSV Rapidly Increases Glucose Transporter Gene TranscriptionScience, 1987
- Enzymology of Cancer CellsNew England Journal of Medicine, 1977